Literature DB >> 19331539

Pilot study of targeting magnetic carbon nanotubes to lymph nodes.

Feng Yang1, Jianhua Hu, Dong Yang, Jiang Long, Guopei Luo, Chen Jin, Xianjun Yu, Jin Xu, Changchun Wang, Quanxing Ni, Deliang Fu.   

Abstract

AIM: The lymphatic distribution of magnetic carbon nanotubes was studied in vivo and compared with magnetic-activated carbon particles, which were selectively taken up in the lymphatic channels and delivered to the regional lymph nodes. MATERIAL &
METHODS: Magnetic multiwalled carbon nanotubes functionalized with poly(acrylic acid) (mMWNTs) and magnetic-activated carbon particles were subcutaneously injected in mice. The draining lymph nodes were harvested at different times postadministration to examine the lymphatic distribution of these particles. The short-term accumulation and toxicity of mMWNTs in the major organs were studied.
RESULTS: mMWNTs had the same properties of lymph node mapping as magnetic-activated carbon particles in mice independent of lymph node metastasis. The degree of black staining of lymph nodes and concentration of mMWNTs had a dose-response relationship. Aggregation of magnetic particles was found around the metastatic foci within the lymph nodes. Footpad injection of mMWNTs did not cause any obvious local or systemic toxicities, and no particle agglomerates were found in the major organs.
CONCLUSION: The feasibility of targeting magnetic carbon nanotubes to lymph nodes was demonstrated and the results support further studies for their potential use in diagnosing and treating cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331539     DOI: 10.2217/nnm.09.5

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  10 in total

Review 1.  Targeted drug delivery in pancreatic cancer.

Authors:  Xianjun Yu; Yuqing Zhang; Changyi Chen; Qizhi Yao; Min Li
Journal:  Biochim Biophys Acta       Date:  2009-10-22

2.  Glucose-Based Mesoporous Carbon Nanospheres as Functional Carriers for Oral Delivery of Amphiphobic Raloxifene: Insights into the Bioavailability Enhancement and Lymphatic Transport.

Authors:  Yanghuan Ye; Tianpeng Zhang; Wan Li; Hua Sun; Danyi Lu; Baojian Wu; Xingwang Zhang
Journal:  Pharm Res       Date:  2015-11-09       Impact factor: 4.200

3.  Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes.

Authors:  Sheng-Tao Yang; Jianbin Luo; Qinghan Zhou; Haifang Wang
Journal:  Theranostics       Date:  2012-03-05       Impact factor: 11.556

4.  Carbon nanotubes in cancer therapy and drug delivery.

Authors:  Abdelbary M A Elhissi; Waqar Ahmed; Israr Ul Hassan; Vinod R Dhanak; Antony D'Emanuele
Journal:  J Drug Deliv       Date:  2011-10-18

Review 5.  Carbon nanotubes as cancer therapeutic carriers and mediators.

Authors:  Kuk Hui Son; Jeong Hee Hong; Jin Woo Lee
Journal:  Int J Nanomedicine       Date:  2016-10-07

6.  Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation.

Authors:  Kati Erdmann; Jessica Ringel; Silke Hampel; Manfred P Wirth; Susanne Fuessel
Journal:  Beilstein J Nanotechnol       Date:  2017-06-23       Impact factor: 3.649

Review 7.  Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review.

Authors:  Madhuchandra Kenchegowda; Mohamed Rahamathulla; Umme Hani; Mohammed Y Begum; Sagar Guruswamy; Riyaz Ali M Osmani; Mysore P Gowrav; Sultan Alshehri; Mohammed M Ghoneim; Areej Alshlowi; Devegowda V Gowda
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

8.  Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Authors:  Marie-Claude F Jaurand; Annie Renier; Julien Daubriac
Journal:  Part Fibre Toxicol       Date:  2009-06-12       Impact factor: 9.400

9.  Experimental Study of Magnetic Multi-Walled Carbon Nanotube-Doxorubicin Conjugate in a Lymph Node Metastatic Model of Breast Cancer.

Authors:  Jian Ji; Minfeng Liu; Yue Meng; Runqi Liu; Yan Yan; Jianyu Dong; Zhaoze Guo; Changsheng Ye
Journal:  Med Sci Monit       Date:  2016-07-07

10.  LyP-1-fMWNTs enhanced targeted delivery of MBD1siRNA to pancreatic cancer cells.

Authors:  Quan-Jun Lin; Zhi-Bo Xie; Ya Gao; Yi-Fan Zhang; Lie Yao; De-Liang Fu
Journal:  J Cell Mol Med       Date:  2020-01-22       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.